Analyst Ratings for Allscripts (MDRX)
MDRX Rating Summary
MDRX Price Target Summary
- Highest: $25.00 (Deutsche Bank)
- Lowest: $7.00 (Piper Jaffray)
- Average: $13.73
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$13.73 (+2.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/12/2013 | Sterne Agee | New Coverage | Buy (N/A) |
17.00 (N/A) |
13.75 | 13.38 | -2.69% | Details |
| 6/4/2013 | Goldman Sachs | New Coverage | Neutral (N/A) |
15.00 (N/A) |
13.76 | 13.38 | -2.76% | Details |
| 5/23/2013 | Raymond James | Downgrade | Outperform (Strong Buy) |
N/A (N/A) |
13.96 | 13.38 | -4.15% | Details |
| 5/14/2013 | Citi | Upgrade | Buy (Neutral) |
N/A (N/A) |
13.61 | 13.38 | -1.69% | Details |
| 4/26/2013 | Morgan Stanley | Upgrade | Overweight (Equalweight) |
N/A (N/A) |
13.35 | 13.38 | 0.22% | Details |
| 4/18/2013 | Maxim Group | Downgrade | Hold (Buy) |
N/A (N/A) |
12.93 | 13.38 | 3.48% | Details |
| 3/28/2013 | B. Riley | New Coverage | Neutral (N/A) |
11.50 (N/A) |
13.64 | 13.38 | -1.91% | Details |
| 2/27/2013 | Credit Suisse | Upgrade | Outperform (Neutral) |
N/A (N/A) |
12.35 | 13.38 | 8.34% | Details |
| 1/7/2013 | Avondale Partners | Upgrade | Market Outperform (Underperform) |
11.50 (N/A) |
9.37 | 13.38 | 42.8% | Details |
| 12/21/2012 | Argus | Downgrade | Hold (Buy) |
N/A (N/A) |
9.14 | 13.38 | 46.39% | Details |
| 11/27/2012 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
12.36 | 13.38 | 8.25% | Details |
| 11/9/2012 | Piper Jaffray | Downgrade | Underweight (Neutral) |
7.00 (12.00) |
12.26 | 13.38 | 9.14% | Details |
| 10/1/2012 | Cowen | Upgrade | Outperform (Neutral) |
N/A (N/A) |
12.42 | 13.38 | 7.73% | Details |
| 10/1/2012 | ISI Group | Upgrade | Buy (Neutral) |
N/A (N/A) |
12.42 | 13.38 | 7.73% | Details |
| 8/9/2012 | JPMorgan | Upgrade | Overweight (Neutral) |
N/A (N/A) |
9.60 | 13.38 | 39.38% | Details |
